Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GANCICLOVIR vs GEMCITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GANCICLOVIR vs GEMCITABINE: Safety Overview

Metric GANCICLOVIR GEMCITABINE
Total FAERS Reports 4,990 31,328
Deaths Reported 1,469 5,142
Death Rate 29.4% 16.4%
Hospitalizations 1,735 12,268
Average Patient Age 41.7 yrs 61.2 yrs
% Female Patients 41.5% 48.4%
FDA Approval Date Dec 12, 1997 Apr 11, 2016
Manufacturer Pharmascience Inc. Hikma Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued